As stated above, down-regulation of either hepatic BMP-9 expression or reduction of the circulating serum levels of BMP-9 protein seems to generally occur during conditions of wound healing and regeneration [4] as well as with increasing age, at least in humans [15], or in pathologic conditions like adiposity or diabetes (see below). The gene discussed is GDF2; the disease is diabetes mellitus.